Centre Asset Management, LLC Abb Vie Inc. Transaction History

Centre Asset Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$137.6 - $154.97 $322,121 - $362,784	-2,341 Reduced 11.68%	17,702 $2.74 Million
Q3 2023 Oct 12, 2023	SELL	$133.59 - $154.65 $93,245 - $107,945	-698 Reduced 3.37%	20,043 $2.99 Million
Q2 2023 Jul 06, 2023	BUY	$132.51 - $164.9 $90,504 - $112,626	683 Added 3.41%	20,741 $2.79 Million
Q1 2023 Apr 03, 2023	BUY	$144.61 - $166.54 $45,841 - $52,793	317 Added 1.61%	20,058 $3.2 Million
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $45,780 - $54,902	331 Added 1.71%	19,741 $3.19 Million
Q3 2022 Oct 04, 2022	BUY	$134.21 - $153.93 $2,952 - $3,386	22 Added 0.11%	19,410 $2.61 Million
Q2 2022 Jul 06, 2022	BUY	$137.62 - $174.96 $2.67 Million - $3.39 Million	19,388 New	19,388 $2.97 Million
Q1 2022 Apr 13, 2022	SELL	$131.98 - $163.75 $3.64 Million - $4.52 Million	-27,585 Closed	0 $0
Q4 2021 Jan 11, 2022	BUY	$107.43 - $135.93 $2.96 Million - $3.75 Million	27,585 New	27,585 $3.74 Million
Q4 2018 Jan 14, 2019	SELL	$77.85 - $96.01 $4.1 Million - $5.05 Million	-52,640 Closed	0 $0
Q3 2018 Oct 03, 2018	SELL	$88.91 - $98.84 $263,173 - $292,566	-2,960 Reduced 5.32%	52,640 $4.98 Million
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $322,310 - $381,365	-3,590 Reduced 6.07%	55,600 $5.15 Million
Q1 2018 Apr 25, 2018	BUY	$92.01 - $123.21 $319,274 - $427,538	3,470 Added 6.23%	59,190 $5.6 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $4.99 Million - $5.47 Million	55,720	55,720 $5.39 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Centre Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Centre Asset Management, LLC with notifications on news.